US 11655455
Enhanced systems for cell-mediated oncolytic viral therapy
granted A61KA61K35/28A61K35/768
Quick answer
US patent 11655455 (Enhanced systems for cell-mediated oncolytic viral therapy) held by Calidi Biotherapeutics, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Calidi Biotherapeutics, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 63
- CPC classes
- A61K, A61K35/28, A61K35/768, A61K39/39, A61K45/06